🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

This study is based on a Norwegian cohort of patients with #solitaryfibroustumor 🇳🇴 The first study from Tatiana Georgiesh showed that late recurrences are quite common and a new risk score to predict outcome was proposed👇 onlinelibrary.wiley.com/doi/full/10.11…

Chemotherapy in patients >40 years with dedifferentiated chondrosarcoma is feasible and shows favorable outcome👍🏼New paper by Ivar Hompland Oslounivsykehus and European colleagues ejcancer.com/article/S0959-… Kirsten Sundby Hall #sarcoma #chondrosarcoma

Happy to share our work on “epigenetic” liquid biopsies in childhood cancer, published today in Nature Communications. Joint work with Christoph Bock Lab @ CeMM & MedUni Vienna CeMM St. Anna Children's Cancer Research Institute CCRI nature.com/articles/s4146….

Endelig👏👏Et steg i riktig retning, men fortsatt en vei å gå. Potensielt svært viktig for enkelte pasienter med tidlig tilgang til nye medikamenter 💊

Updated Soft Tissue and Visceral #Sarcomas: ESMO-EURACAN-GENTURIS Clinical Practice Guidelines for diagnosis, treatment & follow-up. Key management recommendations by a multidisciplinary group of experts from different institutions & countries ow.ly/zAqp50FBk3a #scmsm #sts

#TARPSWG #Education Committee is launching 5❗️free❗️live❗️interactive❗️educational webinars about #retroperitoneal #sarcoma. Stellar panel for webinar #1 kicking off Sep 9 🇨🇦🇮🇹🇬🇧🇺🇸 Register here: forms.gle/odP1KEnJ7wDdzN… European Society of Surgical Oncology (ESSO) Sarcoma European LatinAmerican Network (SELNET) SPAGN

Congratulations Joachim Thorkildsen Brilliant work on #chondrosarcoma in 🇳🇴 and a great defense yesterday👌And thanks to Lee Jeys and Mikael Skorpil for wonderful opposition!@Oslounivsykehus UiO - Det medisinske fakultet RadiumLegat

Great news! Hopefully soon available for Norwegian GIST patients 🤞🤞

We have dedicated information which has been written for patients, their families and friends, and the general public to help them understand more about primary bone cancer, symptoms and how it is diagnosed and treated. Access our free resources here: bcrt.org.uk/information

Intet mindre enn imponerende Bjørn Einar Romøren 💪👊🙌🥇Takk for at du gir #sarkom og kreftsaken et ansikt 🙏 @Kreftforeningen Oslounivsykehus

Happy to see our paper published. A great collaborative effort. miR-486-5p expression is regulated by DNA methylation in osteosarcoma bmcgenomics.biomedcentral.com/articles/10.11… ous-research Norwegian Sarcoma Group Heidi Maria Namløs @GuroLind sarcoma Genomics and Bioinformatics Core Facilities Oslo

Nytt nasjonalt handlingsprogram for sarkom er publisert i dag 👇👇 Viktig arbeid fra et samlet norsk sarkommiljø 👌 #sarkom Helsedirektoratet 🇸🇯 Directorate of Health Oslounivsykehus Haukeland UNN St. Olavs hospital helsedirektoratet.no/retningslinjer…

Soon open in Norway as well! Oslounivsykehus UNN

Happy to share our recent work on risk stratification in solitary fibrous tumor👇Great worldwide collaboration in the #sarcoma community! Tatiana Georgiesh Patrick Schöffski Leonardo A. Meza-Zepeda Andrea Napolitano Herbert Loong, MBBS, FASCO Robin Lewis Jones Anna M. Czarnecka Paul Huang Lab nature.com/articles/s4141…

First face to face Foster meeting at Gustave Roussy. Fighting #osteosarcoma through collaboration and research. Strong presence from Norway Kjetil Boye Jørgen Wesche Mariike Kuijjer ous-research

Important and highly needed initiative for #osteosarcoma patients!

Den store kuledagen - fagdag om sarkom for primærhelsetjenesten på Oslounivsykehus i dag. Nesten fullt hus og strålende foredragsholdere🤩#sarkom

Great to have contributed to this large international effort for sarcomas ous-research Norwegian Sarcoma Group @MyklebostOla Heritable defects in telomere and mitotic function selectively predispose to sarcomas science.org/doi/10.1126/sc…

High-risk GIST patients receive 3 years of adjuvant imatinib, but almost half of these patients are cured by surgery alone. We hypothesized that genomic complexity could be a biomarker to identify high-risk patients who don’t need additional therapy. ascopubs.org/doi/abs/10.120…

➡️Could de-escalation of adjuvant imatinib treatment be of benefit for patients with cytogenetically simple #GIST❓ Oslounivsykehus Norwegian Sarcoma Group @helsesorost #sarcoma ous-research